SJB-3-019-A | Interleukin Related interleukin-related.com

Product Name :
SJB-3-019-A

Search keywords :
SJB3-019A

drugId :
null

Target Vo:
Ubiquitin carboxyl-terminal hydrolase 1

Target Vo Short Name :
USP1

Moa_Name:
Ubiquitin carboxyl-terminal hydrolase 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Dana-Farber Cancer Institute

Active Company_Name :
Dana-Farber Cancer Institute

Active Indication_Name:
Multiple Myeloma

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
MRC1 Antibody
Ubiquitin D Antibody
MAP2 Antibody: MAP2 Antibody is an unconjugated, approximately 60 kDa, rabbit-derived, anti-MAP2 polyclonal antibody. MAP2 Antibody can be used for: WB, IF-Cell, IHC-P expriments in human, mouse, rat background without labeling.

Author: Interleukin Related

Related Posts